Existing data shows that Ack1 is amplified or mutated in breast, ovarian [53], colorectal cancers [54], esophageal squamous cell carcinoma [55], non-small-cell lung cancer [56], osteosarcoma [57], and chronic myelomonocytic leukemia [58]. This evidence concerns the gene TNK2 and chronic myelomonocytic leukemia.